Zobrazeno 1 - 10
of 563
pro vyhledávání: '"drug-coated balloons"'
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Drug-coated balloons (DCBs) angioplasty is safe and effective for coronary artery disease. However, DCBs dilatation for the treatment of benign esophageal strictures is rarely reported. Purpose We aimed to report the clinical outc
Externí odkaz:
https://doaj.org/article/05d982af187c4128abc02c0d8ab9c358
Autor:
Nicholas Weight, Mamas A. Mamas
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 23 (2024)
Externí odkaz:
https://doaj.org/article/db3f265c01554df286932c925815dcd6
Publikováno v:
International Journal of Pharmaceutics: X, Vol 7, Iss , Pp 100230- (2024)
Drug-coated balloons (DCBs) are effective tools for cardiovascular interventions, ensuring uniform drug delivery to occluded arteries. This research investigates the potential of Pluronic P123 (P123), a micelle-forming polymer, to solubilize and rele
Externí odkaz:
https://doaj.org/article/f191741b2ba748c3bb78c01cf1ea6cf6
Publikováno v:
Lipids in Health and Disease, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Background The pathogenetic mechanism of atherosclerotic cardiovascular diseases is associated with insulin resistance (IR), which serves as a metabolic risk factor. As a novel indication for IR, triglyceride-glucose (TyG) index may predict
Externí odkaz:
https://doaj.org/article/97d182c5f089451095292883cc790ffd
Autor:
Mehdi Madanchi, Adrian Attinger-Toller, Varis Gjergjizi, Irena Majcen, Giacomo M. Cioffi, Angelika Epper, Eleonora Gnan, Tanja Koch, Yuan Zhi, Florim Cuculi, Matthias Bossard
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundThere is mounting data supporting the use of drug-coated balloons (DCB) not only for treatment of in-stent restenosis (ISR), but also in native coronary artery disease. So far, paclitaxel-coated balloons represented the mainstay DCBs. The S
Externí odkaz:
https://doaj.org/article/a4843cae1e1845afa4ffab839924d7e5
Publikováno v:
Vascular Health and Risk Management, Vol Volume 19, Pp 133-137 (2023)
Nicolas W Shammas, Gail Shammas, Lori Christensen, Sue Jones-Miller On behalf of the JET-RANGER InvestigatorsMidwest Cardiovascular Research Foundation, Davenport, IA, USACorrespondence: Nicolas W Shammas, Research Director, Midwest Cardiovascular Re
Externí odkaz:
https://doaj.org/article/aca7896decf44737a57aa3a2633d27ec
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 25, Iss 4, p 116 (2024)
Background: Drug-coated balloons (DCBs) have become increasingly vital to percutaneous coronary intervention, offering many advantages. However, a significant challenge is that many patients are intolerant to the myocardial ischemia caused by DCB dil
Externí odkaz:
https://doaj.org/article/f4838c283f54477db50156d7bfee946d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Vascular Health and Risk Management, Vol Volume 18, Pp 603-615 (2022)
Nicolas W Shammas,1 Bhaskar Purushottam,2 W John Shammas,1 Lori Christensen,1 Gail Shammas,1 Desyree Weakley,1 Sue Jones-Miller1 On behalf of the JET-RANGER Investigators1Midwest Cardiovascular Research Foundation, Davenport, IA, USA; 2Regional Healt
Externí odkaz:
https://doaj.org/article/36784f8aa4924ff4a6e36f9ada144246